11:57 EDT Cel Sci trading halted, news pending
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVM:
- CEL-SCI teams with Saudi Arabia pharmaceutical, healthcare company for Multikine
- Biotech Alert: Searches spiking for these stocks today
- CEL-SCI 2M share Spot Secondary priced at $2.50
- CEL-SCI announces common stock offering, no amount given
- CEL-SCI completes Breakthrough Medicine Designation application for Multikine
